Diversity and Health Equity Highlights at the Annual Meeting
As we convene at the American Psychiatric Association Annual Meeting, we encourage the psychiatrists and mental health professionals in attendance to seize the opportunity to deepen our understanding of diversity and health equity by attending the following sessions. These sessions offer invaluable insights into addressing disparities, fostering inclusivity, and enhancing culturally competent care, empowering us to better serve the diverse needs of our patients and communities. Join us in advancing equity in mental health care and expanding our collective impact as compassionate and effective mental health professionals.
"E3 of AI: Equity, Errors, and Ethics of Artificial Intelligence in Vulnerable Populations with Substance Use Disorder"
- Saturday, May 4
- 10:30 a.m. - Noon ET
The presentation delves into the groundbreaking impact of artificial intelligence (AI) in tackling addiction-related disparities prevalent in communities of color, with a specific focus on its integration within the field of psychiatry. It will highlight the innovative potential of AI in enhancing both prevention and treatment strategies and in broader outreach within marginalized communities and explore how AI can revolutionize current practices.
"Telemedicine and Addiction Treatment: The potential implications for marginalized populations (in relation to the Ryan Haight Act)"
On-Site
- Sunday, May 5
- 1:30 p.m. - 3:00 p.m. ET
Virtual Session Replay
- Monday, May 6
- Noon - 1:30 p.m. ET
During the COVID-19 pandemic, the administration swiftly expanded telehealth services for medications used in opioid use disorders (MOUD) and mental health conditions covered by the Act, resulting in enhanced access to MOUD, improved patient retention in care, and reduced risks of medically treated overdoses. The APA advocates for permanently removing the in-person requirement for prescribing controlled substances via telehealth. Speakers will delve into the current status of this legislative initiative and its potential effects on minoritized and marginalized communities in the United States.
"Pregnancy & Buprenorphine: To offer or not offer, that is the question"
- Monday, May 6
- 8:00 a.m. - 9:30 p.m. ET
While untreated opioid use disorder poses significant health risks to both mother and fetus, buprenorphine offers a safer alternative by stabilizing opioid use, mitigating overdose risk, and alleviating withdrawal symptoms. However, the decision to use buprenorphine during pregnancy involves complex clinical considerations. This presentation will explore these considerations in depth, shedding light on the nuanced medical factors that providers must weigh when determining the appropriate course of treatment.
"Model Programs That Address SDOMH and Addictions in Marginalized Communities"
- Sunday, May 5
- 1:30 p.m. - 3:00 p.m. ET
Recognizing the pressing need for further research into social determinants of mental health (SDOMH) and their impact on health disparities, particularly in the realm of addiction, the session aims to shed light on effective strategies to reduce the burden of substance use disorders – a leading cause of premature death and disability in the United States. Central to this discussion is the imperative to prioritize marginalized communities in efforts to advance health equity.
"Moving Beyond the SCOTUS Affirmative Action Decisions: Ensuring a 21st Century Psychiatric Workforce"
- Monday, May 6
- 3:45 p.m. - 5:15 p.m. ET
On June 29, 2023, the Supreme Court of the United States (SCOTUS) voted in a 6-3 decision to end a four-decade precedent that allowed colleges and universities to consider race as one factor in a holistic review admissions process. How can we continue to ensure a 21st century psychiatric workforce ready to meet the current and future needs of a diverse patient population? The panelists will provide a brief history and overview of the purpose of affirmative action, discuss the potential impact of this decision on medical education and diversity in psychiatry.
"Alternative Harm Reduction Approaches for Treating Addiction in Minoritized Communities"
- Wednesday, May 8
- 8:00 a.m. - 9:30 a.m. ET
Harm reduction psychotherapy (HRP) is a pioneering treatment model designed for individuals grappling with alcohol or substance use disorders. Diverging from conventional methods, HRP employs a comprehensive biopsychosocial approach to comprehensively grasp the intricacies of drug use, abuse, and addiction.
"Your Voice Is Critical: Update on maternal mental health in communities of color"
- Tuesday, May 7
- 1:30 p.m. - 3:00 p.m. ET
By examining the pivotal role of mental health care providers in enhancing outcomes, participants will explore recent policies, legislation, research findings, best practices, and cultural competencies essential for advocating effectively for birthing individuals of color. Attendees will gain invaluable insights into combating maternal mental health disparities within communities of color, ultimately fostering more equitable and healthier outcomes for both parents and their children.